20
Biofer Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HEPARIN SODIUM, with a corresponding US DMF Number 22348.
Remarkably, this DMF maintains an Active status since its submission on December 22, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 03, 2019, and payment made on February 06, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II